ASSESSMENT OF LIFE QUALITY IN PATIENTS WITH STAGE IIB-IIIB SQUAMOUS CELL CERVICAL CANCER RECEIVING PACLITAXEL CISPLATIN CHEMOTHERAPY REGIMEN BY EORTC QLQ-C30 QUESTIONNAIRE IN SANGLAH HOSPITAL DENPASAR
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 9, Issue 5
Abstract
Objective: Cervical cancer was the prominent cause of women's death in developing states. Decrease in life quality was often encountered by patients with cervical cancer in advanced stages. One treatment method of cervical cancer at Sanglah Hospital was using paclitaxel cisplatin chemotherapy. Information on cervical cancer patient's life quality who received paclitaxel cisplatin chemotherapy was still limited, so research was required to observe cervical cancer patients’ life quality before the first and after the sixth paclitaxel cisplatin chemotherapy regimen.Methods: Observational study with prospective case study design was undertaken at the Polyclinic of Obstetrics and Gynecology Sanglah Hospital from January to August 2016. Sampling was conducted before chemotherapy I and after chemotherapy VI using consecutive sampling method. The EORTC QLQ C30 questionnaires were completed by the patients before chemotherapy I and after chemotherapy VI. Patients' life quality who had received paclitaxel cisplatin chemotherapy were assessed with 15 domains in EORTC QLQ C30 questionnaire. The data obtained were processed with STATA® version 14 and analysed using paired t test and Wilcoxon test with a confidence level of 95%.Results: The number of samples used in this study was 7 patients who received paclitaxel cisplatin chemotherapy. The results of the analysis showed that there were differences in cervical cancer patients’ life quality who had received paclitaxel cisplatin regimen chemotherapy before chemotherapy I and after chemotherapy VI with the result of p-value is 0.0005.Conclusion: There was a significant decrease in the value of cervical cancer patients' life quality who received paclitaxel cisplatin chemotherapy before chemotherapy I and after chemotherapy VI.
Authors and Affiliations
Rini Noviyani, Putu Ayu Indrayathi, I Nyoman Gede Budiana, Ketut Suwiyoga
Keywords
Related Articles
- EP ID EP575659
- DOI 10.22159/ijpps.2017v9i5.17621
- Views 80
- Downloads 0
CURRENT STATUS OF EPILEPSY IN MALAYSIA AND WAY AHEAD
Epilepsy is the third most common neurological disorder, following stroke and Alzheimer’s disease with the highest frequency of newly identified cases occurring among children and adults. About 50 million people worldw...
COMPARISON OF COMMERCIALLY AVAILABLE DRUGS FOR TYPE 2 DIABETES WITH NATURAL MOLECULE FROM TINOSPORA
Objective: Efficacy of natural molecule from Tinospora cordifolia versus commercially available drugs to control diabetes 2.Methods: Twelve different drug molecules were selected to study drug properties, bioactivity and...
CHEMICAL COMPOSITION OF THE HEXANE EXTRACT OF LEAVES OF AZIMA TETRACANTHA (LAM)
Objective: In the present study, the phytochemical constituents of hexane extract from Azima tetracantha (AT) leaves were done by using Gas Chromatography Mass Spectrometry analysis technique (GC-MS). Azima tetracantha h...
ANALYSIS OF 4-HYDROXYCYCLOPHOSPHAMIDE IN CANCER PATIENTS PLASMA FOR THERAPEUTIC DRUG MONITORING OF CYCLOPHOSPHAMIDE
Objective: To quantify 4-hydroxycyclophosphamide in cancer patients’ plasma for therapeutic drug monitoring of cyclophosphamide.Methods: The blood was collected at 0.5 and 1 h after administration of chemotherapy. Prio...
ANTI-CANCER EFFECT OF OCIMUM SANCTUM ETHANOLIC EXTRACT IN NON-SMALL CELL LUNG CARCINOMA CELL LINE
Objective: The present study was aimed to investigate the effects of alcoholic root extract of Ocimum sanctum, in human non-small cell lung carcinoma cell (NCI-H460).Methods: The effect of ethanolic extract of O. sanctum...